Home › Funds › GREAT POINT PARTNERS LLC › CLYM

GREAT POINT PARTNERS LLC position in CLYM

CLIMB BIO INC · Health Care

GREAT POINT PARTNERS LLC reported holding 1,000,000 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$13.0M, representing 2.74% of its reported portfolio and ranking #16 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed CLYM holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.00M sh
Reported value held$13.04M
Portfolio Weight2.74%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's CLYM position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in CLYM in Q3 2024 at 248,168 shares (US$1.3M). The position peaked in Q2 2026 at 1,000,000 shares, worth US$13.0M. Across 4 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,000,000 shares valued at US$13.0M — a reduction of -334,130 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2026 (shares rose 90% over the following quarter), a 25% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 248.17K $1.26M New
Q4 2025 979.53K $3.92M New
Q1 2026 1.33M $9.14M Add
Q2 2026 1.00M $13.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLYM and 13F data

CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLYM

All CLYM fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held CLYM?

GREAT POINT PARTNERS LLC has disclosed CLYM holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

What is GREAT POINT PARTNERS LLC's current position in CLYM?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 1.00M shares of CLYM (CLIMB BIO INC), valued at $13.04M, representing 2.74% of its reported portfolio and ranking #16.

Has GREAT POINT PARTNERS LLC been buying or selling CLYM?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC reduced its position in CLYM. The position peaked in Q2 2026 at 1.00M shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.